Here’s What Hedge Funds Think About Lexicon Pharmaceuticals, Inc. (LXRX)
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by......(read more)
Posts Tagged ‘NASDAQ:LXRX’
Hedge Fund and Insider Trading News: Bill Ackman, Jana Partners, BlueCrest Capital Management, Iqvia Holdings Inc (IQV), Twelve Seas Investment Company (TWLVU), ABIOMED, Inc. (ABMD), and More
Bill Ackman Makes More Layoffs at His Pershing Square Hedge Fund (CNBC) Billionaire hedge fund manager William Ackman, whose investment assets have shrunk......(read more)
Hedge Fund and Insider Trading News: Paul Tudor Jones, Rob Citrone, Facebook, Inc. (FB), Christopher & Banks Co. (CBK), Lexicon Pharmaceuticals, Inc. (LXRX), and More
‘Capitalism May Need Modernizing,’ Says Billionaire Hedge Fund Manager Paul Tudor Jones (CNBC) The 50-year-old definition of capitalism in......(read more)
Here’s What’s Next For Lexicon Pharmaceuticals, Inc. (LXRX) And Dynavax Technologies Corporation (DVAX)
Two companies have logged strong starts to the week in the biotech space so far, and both are moving on FDA driven catalysts. Here’s a look at these......(read more)
Biotech Movers And Shakers: Lexicon Pharmaceuticals, Inc. (LXRX) And Neuroderm Ltd (NDRM)
Right then, it’s time to take a look at who moved during the start of this week, and what’s driving the action in the biotech sector. In a continuation......(read more)
Lexicon Pharmaceuticals, Inc. (LXRX): Are Hedge Funds Right About This Stock?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the......(read more)
Two Biotechs With Bad News This Week: What Happens Now?
When things go well in biotech, it can be a great ride. When things repeatedly go well, however, it can be easy to forget how quickly, and how frequently......(read more)
Delving Into The Lexicon Pharmaceuticals, Inc. (LXRX) Data
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) gained considerably at the end of last week on the back of a data release from its ongoing type 1 diabetes......(read more)
Do Investors Like Lexicon Pharmaceuticals, Inc. (LXRX) or Ariad Pharmaceuticals, Inc. (ARIA) More?
It is already common knowledge that individual investors do not usually have the necessary resources and ability to properly research an investment opportunity......(read more)
These Biotech Stocks Move in Opposing Directions Today and Hedge Funds Say You Should Bet on One of Them
Shares of Heron Therapeutics Inc (NASDAQ:HRTX) are up by more than 20% in early trading, following positive Phase 2 reports on HTX-011, an anesthetic......(read more)
Lexicon Pharmaceuticals, Inc. (LXRX) Flies On Cancer Drug Study Results; Hedge Funds Saw This Coming
Shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) are flying high today, gaining nearly 60% on Monday, as the company announced positive results for......(read more)
Nektar Therapeutics (NKTR): Insiders Aren’t Crazy About It But Hedge Funds Love It
Is Nektar Therapeutics (NASDAQ:NKTR) a good investment? Now, according to many of your peers, hedge funds are assumed to be useless, outdated investment......(read more)
Acorda Therapeutics Inc (ACOR): Insiders Aren’t Crazy About It But Hedge Funds Love It
To many investors, hedge funds are assumed to be bloated, outdated investment tools of a forgotten age. Although there are In excess of 8,000 hedge funds......(read more)
PDL BioPharma Inc. (PDLI): Hedge Fund and Insider Sentiment Unchanged, What Should You Do?
Should PDL BioPharma Inc. (NASDAQ:PDLI) investors track the following data? In the eyes of many market players, hedge funds are seen as overrated, old......(read more)
Santarus, Inc. (SNTS): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
What should a smart Santarus, Inc. (NASDAQ:SNTS) investor do? In the financial world, there are a multitude of gauges investors can use to watch publicly......(read more)
Hedge Funds Are Selling Sarepta Therapeutics Inc (SRPT)
Is it smart to be bullish on Sarepta Therapeutics Inc (NASDAQ:SRPT)? If you were to ask many of your fellow readers, hedge funds are seen as overrated......(read more)
Lexicon Pharmaceuticals, Inc. (LXRX), Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK): Why Clinical Trials Fail
Drugs fail their clinical trials for all kinds of reasons. Sometimes, it’s related to efficacy; sometimes, it’s safety related. Most of the......(read more)
What Hedge Funds Think About VIVUS, Inc. (VVUS)
Are you curious what the richest investors think about VIVUS, Inc. (NASDAQ:VVUS)? In the 21st century investor’s toolkit, there are dozens of metrics......(read more)
Lexicon Pharmaceuticals, Inc. (LXRX), Merck & Co., Inc. (MRK): The Worst-Performing Biotech Stocks of the Last Decade
Suppose we filled a jar with slips of paper with the names of biotech companies that have been around for at least 10 years and with a market cap of at......(read more)
Lexicon Pharmaceuticals, Inc. (LXRX): Insiders Aren’t Crazy About It
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) investors should pay attention to an increase in activity from the world’s largest hedge funds recently......(read more)
Is Nektar Therapeutics (NKTR) Going to Burn These Hedge Funds?
Nektar Therapeutics (NASDAQ:NKTR) was in 8 hedge funds’ portfolio at the end of March. NKTR has experienced a decrease in support from the world......(read more)
Amarin Corporation plc (ADR) (AMRN), Lexicon Pharmaceuticals, Inc. (LXRX): Which of These Billion-Dollar Biotechs Is a Buy?
Regardless of Anchor, Things Are Looking Up! It has been a rough year for Amarin Corporation plc (ADR) (NASDAQ:AMRN) and its long-term investors. The......(read more)
Santarus, Inc. (SNTS): Insiders Are Buying, Should You?
Santarus, Inc. (NASDAQ:SNTS) investors should pay attention to a decrease in hedge fund interest in recent months. If you’d ask most shareholders......(read more)
This Metric Says You Are Smart to Buy Sarepta Therapeutics Inc (SRPT)
Sarepta Therapeutics Inc (NASDAQ:SRPT) was in 19 hedge funds’ portfolio at the end of March. SRPT shareholders have witnessed an increase in enthusiasm......(read more)
Acorda Therapeutics Inc (ACOR): Insiders Are Dumping, Should You?
Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds’ portfolio at the end of the fourth quarter of 2012. ACOR investors should pay attention......(read more)
Pacific Biosciences of California (PACB), Lexicon Pharmaceuticals, Inc. (LXRX): 3 Stocks With Insider Interest
The global economy is still going through the initial stages of recovery and waiting on positive news from European markets. This bad economy has created......(read more)
